Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Deadline Approaching: Apply for the Fierce AI Innovation Awards
companion diagnostics
MedTech
Roche shells out up to $1B for PathAI to boost AI diagnostics
Roche will pay more than $1 billion to acquire digital pathology specialist Path AI in a move to bolster its use of artificial intelligence.
Joseph Keenan
May 7, 2026 9:30am
Roche nets FDA breakthrough label for AI lung cancer CDx test
Apr 29, 2025 2:07pm
Qiagen, AstraZeneca expand DNA test collaboration beyond cancer
Aug 29, 2024 11:30am
Agilent, Incyte ink hematology, oncology companion testing deal
Jan 30, 2024 12:28pm
Agilent shuts down its Resolution cancer diagnostic business
Aug 22, 2023 10:20am
Tempus clocks FDA approval for 648-gene cancer test
May 8, 2023 8:05am